| Management of benign prostatic hyperplasia by family physicians. | |
| | |
MedLine Citation:
|
PMID: 20170598 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The past decade has profoundly changed how physicians manage patients with benign prostatic hyperplasia (BPH). The concepts of symptom indices, symptom complexes, flow rates, prostate-specific antigen (PSA), prostate size and new medical approaches supported by new clinical studies, have provided family practitioners as well as specialists with evidence-based management algorithms to treat BPH. Men with BPH most often visit a physician due to their partner's urging because of the many symptoms, with the most bothersome being nocturia. Today, primary care physicians are the gatekeepers for diagnosing and managing lower urinary tract symptoms (LUTS) in men. They need to be aware of long term negative consequences if these major symptoms are not treated early. |
| | |
Authors:
|
Allan Toguri; Jack Barkin |
Related Documents
:
|
20469478 - Family medicine in the undergraduate curriculum: differing views on where from here? 20469408 - Family medicine education in canada, 1983. 15812688 - Papaya: a simulation model for training in uterine aspiration. 7796898 - Are primary care residents adequately prepared to care for women of reproductive age? 19029108 - Feeding practices and the use of supplements for dogs kept by owners in different socio... 4812408 - Benorylate in management of still's disease. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The Canadian journal of urology Volume: 17 Suppl 1 ISSN: 1195-9479 ISO Abbreviation: Can J Urol Publication Date: 2010 Feb |
Date Detail:
|
Created Date: 2010-02-22 Completed Date: 2010-05-19 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9515842 Medline TA: Can J Urol Country: Canada |
Other Details:
|
Languages: eng Pagination: 26-34 Citation Subset: IM |
Affiliation:
|
Department of Urology, Scarborough General Hospital, Scarborough, Ontario, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic alpha-Antagonists
/
therapeutic use* Aged Combined Modality Therapy Family Practice / methods*, trends Follow-Up Studies Humans Male Middle Aged Physicians, Family / trends Prostate-Specific Antigen / blood* Prostatic Hyperplasia / complications, diagnosis, therapy* Risk Assessment Severity of Illness Index Transurethral Resection of Prostate Treatment Outcome Urinary Retention / diagnosis, etiology, therapy Urination Disorders / etiology, physiopathology, therapy* Urodynamics |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic alpha-Antagonists; EC 3.4.21.77/Prostate-Specific Antigen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians...
Next Document: Uropharmacology in primary care: 2010 update.